![Page Background](./../common/page-substrates/page0102.png)
100
Chapter 15
Primary Care Otolaryngology
Treatment of papillary carcinoma is somewhat controversial. Historically,
a total thyroid
lobectomy
and
isthmectomy
have been used to treat
smaller papillary thyroid cancers (<1 cm). More recently, the trend has
been toward total thyroidectomy in patients with nodules containing pap-
illary thyroid cancers. Newer evidence from a study by Mazzaferri and
colleagues suggests that
total thyroidectomy,
when compared to subtotal,
may significantly decrease the local recurrence rate (18% versus 7%), and
ultimately the number of deaths (from 1.5% to 0.03%).
1
This study also
points out that patients treated with
radioactive iodine
and
thyroid hor-
mone suppression
have a decreased incidence of recurrence (3%), com-
pared to those treated with thyroid suppression alone (11%). However,
there was no difference in the number of deaths between these two
groups.
As mentioned earlier, if cervical metastatic thyroid cancer is present, a
modified or selective neck dissection
is indicated, depending on the
location of the disease. The greatest risks of thyroid surgery are hypopara-
thyroidism secondary to injury or removal of the parathyroid glands, and
recurrent laryngeal nerve injury,
which may result in hoarseness, short-
ness of breath, and reduced exercise tolerance.
Follicular Carcinoma
Approximately 15 percent of thyroid cancers is the follicular cell type. The
surgical specimen of all thyroid cancers must be sectioned completely to
determine if the tumor capsule and/or lymphatic and blood vessels are
invaded. The findings of capsular and/or lymphovascular invasion are
essential for diagnosis
and cannot be determined by a fine-needle aspi-
rate. Cytopathologically, the cells may also look fairly benign on fine-nee-
dle aspirate, so many specimens are interpreted as “consistent with adeno-
ma, cannot rule out follicular carcinoma.” This tumor metastasizes via the
blood. Two major types of follicular carcinoma are
microinvasive
and
macroinvasive.
A variant is Hürthle cell carcinoma, which is a more
aggressive form of follicular thyroid cancer and is marked by a high fre-
quency (75% or more) of Hürthle cells.
Like papillary carcinoma, follicular carcinoma has an affinity for radioac-
tive iodine. Since iodine is concentrated in normal thyroid tissue, an
attempt to remove all thyroid tissue allows a higher dose to be delivered to
1
Mazzaferri, E.T., et al. A vision for the surgical management of papillary thyroid carcinoma:
extensive lymph node compartmental dissections and selective use of radioiodine.
Journal of
Clinical Endocrinology & Metabolism
2009 Apr; 94(4):1086-1088.